- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (75)
- Timeline of Article Publication (1)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3442)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 21, 2023 (publication date) through Aug 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen TT, Lv JJ, Chen L, Li M, Liu LP. Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis. World J Gastroenterol 2023; 29(35): 5154-5165 [PMID: 37744293 DOI: 10.3748/wjg.v29.i35.5154] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i35/5154.htm |
| Number | Citing Articles |
| 1 |
Di Chen, Lin-Jun Wang, Hong-Lei Li, Fei Feng, Jian-Chun Li, Liping Liu. Progress of heparanase in septic cardiomyopathy: A review. Medicine 2024; 103(33): e38901 doi: 10.1097/MD.0000000000038901
|
| 2 |
Di Chen, Honglei Li, Shitao Huang, Zhongya Huang, Yibo Sun, Liping Liu. Heparanase inhibitor improves clinical study in patients with septic cardiomyopathy. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1429109
|